The postoperative recurrence of advanced osteosarcoma:3 cases report with a review of literature

Xiu-chun YU,Su-jia WU,Xu-quan WANG,Song-feng XU,Ming XU,Ye YUAN

DOI: https://doi.org/10.3969/j.issn.2095-252X.2013.09.003

2013-01-01

Abstract:Objective To investigate the clinical characteristics and treatment options of the postoperative recurrence of advanced osteosarcoma. Methods The data of 3 patients with postoperative recurrence of advanced osteosarcoma treated in our hospital were analyzed retrospectively, combined with 10 cases of late recurrent osteosarcoma in literature retrieval. There were 8 males and 5 females. The mean age at the moment of recurrence was 25.56 years old ( range;13-42 years ). Locations:5 cases occurred in the distal femur, 2 cases in the distal tibia and acetabulum respectively and 1 case in the proximal tibia, and the rest cases were not described. Histological types:3 cases of ifbroblastic type, 2 cases of traditional type, 2 cases of mixed type, 1 case of osteoblastic type, 1 case of chondroblastic type and 1 case of telangiectasia type, and the rest cases were not described. Recurrent period:an average period of 10.02 years ( range;5.2-19.3 years ). Treatment modalities:5 patients accepted operation and chemotherapy, 1 patient with operation and radiotherapy, 2 patients with operation and 1 patient gave up therapy, and the rest cases were not described. Results 12 cases were followed up for an average period of 2.28 years ( range;6 months-4.7 years ), except that 1 case was lost in this group. 6 patients survived ( up to 4.5 years ), and 6 patients died ( 0.6-4.7 years ). Conclusions No signiifcant speciifcity is found in the clinical characteristics, lesion locations, histologic types and so on in the patients with postoperative recurrence of advanced osteosarcoma. The long-term and regular follow-up in the patients with osteosarcoma should be valued clinically. It is necessary to follow up once every 6 months 5 years after the operation. The abnormal changes in the surgical site should be given more attention at the same time that the exclusion of pulmonary and other metastases is focused on. Once the diagnosis of late postoperative recurrence is conifrmed, operation and chemotherapy are commonly used in the clinical treatment at present. The clinical outcomes remain to be further observed.